Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
Recruiting
Phase 4
Interventional Study
Irritable Bowel Syndrome
Gastrointestinal Diseases
Colonic Diseases, Functional
Intestinal Disease
Digestive System Disease
Pathologic Processes
Colonic Disease
Disease
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- EP Plus Group Sdn Bhd · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this randomized, double-blind, placebo-controlled study is to evaluate the effectiveness of Skal Pro in alleviating symptoms, enhancing stool consistency, improving quality of life, and addressing psychological distress in individuals diagnosed with irritable bowel syndrome (IBS), as compared to those who receive no intervention.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* IBS diagnosed using the Rome IV criteria
* Age above 18 years old and any gender
* Any subtypes of IBS (diarrhea, constipation or mixed)
Exclusion Criteria:
* Presence of red flag symptoms (weight loss, anemia, night symptoms, abdominal mass, strong family history of cancer)…
Contacts